Stock CLBT CELLEBRITE DI LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cellebrite DI Ltd.

Equities

CLBT

IL0011794802

Software

Real-time Estimate Cboe BZX
Other stock markets
 11:23:35 2024-05-29 am EDT 		5-day change 1st Jan Change
10.9 USD -0.95% Intraday chart for Cellebrite DI Ltd. -5.90% +26.15%
May. 24 JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating MT
May. 24 Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating MT

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 1,501 826.7 1,709 2,260 - -
Enterprise Value (EV) 1 1,355 739 1,520 2,041 1,921 1,773
P/E ratio 18.2 x 7.39 x -20.1 x -36.9 x 78.4 x 35.6 x
Yield - - - - - -
Capitalization / Revenue 6.1 x 3.05 x 5.26 x 5.98 x 5.07 x 4.27 x
EV / Revenue 5.5 x 2.73 x 4.67 x 5.4 x 4.31 x 3.35 x
EV / EBITDA 28.3 x 28.5 x 24.5 x 26.4 x 19.8 x 14.7 x
EV / FCF 43.8 x 54 x 15.7 x 19.8 x 14.7 x 11.1 x
FCF Yield 2.28% 1.85% 6.37% 5.05% 6.82% 9.02%
Price to Book -20.5 x 11.4 x 52.2 x 91.7 x 21.3 x 10.9 x
Nbr of stocks (in thousands) 187,169 189,607 197,368 205,255 - -
Reference price 2 8.020 4.360 8.660 11.01 11.01 11.01
Announcement Date 2/16/22 2/15/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 246.2 270.7 325.1 378 445.8 528.7
EBITDA 1 47.9 25.91 61.95 77.33 96.93 121
EBIT 1 42.87 19.54 55.28 70.13 89.96 114.4
Operating Margin 17.41% 7.22% 17% 18.55% 20.18% 21.64%
Earnings before Tax (EBT) 1 82.3 120.8 -75.56 -101.5 33.63 77.8
Net income 1 71.4 120.8 -81.1 -97.02 29.97 73.19
Net margin 28.99% 44.63% -24.95% -25.66% 6.72% 13.84%
EPS 2 0.4400 0.5900 -0.4300 -0.2984 0.1404 0.3096
Free Cash Flow 1 30.94 13.68 96.83 103 131 160
FCF margin 12.57% 5.05% 29.78% 27.25% 29.39% 30.26%
FCF Conversion (EBITDA) 64.59% 52.81% 156.31% 133.19% 135.15% 132.26%
FCF Conversion (Net income) 43.34% 11.32% - - 437.1% 218.61%
Dividend per Share 2 - - - - - -
Announcement Date 2/16/22 2/15/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 65.89 67.91 62.38 62.57 71.68 74.02 71.23 76.68 84.18 93.01 89.58 92.07 95.35 101.5 103.9
EBITDA 1 15.02 8.874 4.082 0.657 5.053 16.11 7.304 11.12 20.79 22.73 17.63 17.41 20.39 23.13 20.9
EBIT 1 13.47 7.751 2.634 -0.936 3.412 14.43 5.653 9.395 19.25 20.98 15.88 15.51 18.8 21.81 19.16
Operating Margin 20.44% 11.41% 4.22% -1.5% 4.76% 19.49% 7.94% 12.25% 22.87% 22.56% 17.73% 16.85% 19.71% 21.5% 18.44%
Earnings before Tax (EBT) 1 14.72 54.12 54.45 32.87 24.34 9.102 -38.64 -31.43 6.849 -12.34 -69.33 -18.6 -16.66 -13.21 -3.65
Net income 1 8.139 51.87 55.44 33.2 25.09 7.078 -40.6 -32.35 6.5 -14.65 -71.37 -14.55 -12.68 -9.646 -0.402
Net margin 12.35% 76.38% 88.86% 53.05% 35.01% 9.56% -57% -42.18% 7.72% -15.75% -79.67% -15.81% -13.3% -9.51% -0.39%
EPS 2 0.0500 0.2500 0.2700 0.1700 0.1300 0.0400 -0.2100 -0.1700 0.0300 -0.0800 -0.3600 0.0118 0.0243 0.0371 -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/10/21 2/16/22 5/12/22 8/11/22 11/17/22 2/15/23 5/10/23 8/8/23 11/14/23 2/15/24 5/23/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 146 87.6 190 219 338 487
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 30.9 13.7 96.8 103 131 160
ROE (net income / shareholders' equity) 156% - 113% 198% 101% 55.5%
ROA (Net income/ Total Assets) 10.8% 5.3% 13% 8.91% 10.2% 11.5%
Assets 1 662.1 2,280 -623.1 -1,089 292.6 636.6
Book Value Per Share 2 -0.3900 0.3800 0.1700 0.1200 0.5200 1.010
Cash Flow per Share 2 0.2200 0.1100 0.5000 0.4700 0.5700 0.7000
Capex 1 5.11 6.9 5.23 8.48 9.62 7.57
Capex / Sales 2.08% 2.55% 1.61% 2.24% 2.16% 1.43%
Announcement Date 2/16/22 2/15/23 2/15/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Cellebrite DI Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
11.01 USD
Average target price
14.36 USD
Spread / Average Target
+30.40%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

1st Jan change Capi.
CELLEBRITE DI LTD. Stock Cellebrite DI Ltd.
+27.14% 2.26B
MICROSOFT CORPORATION Stock Microsoft Corporation
+14.43% 3,198B
SYNOPSYS INC. Stock Synopsys Inc.
+14.18% 90.08B
CADENCE DESIGN SYSTEMS, INC. Stock Cadence Design Systems, Inc.
+8.75% 80.61B
DASSAULT SYSTÈMES SE Stock Dassault Systèmes SE
-14.05% 54.83B
PALANTIR TECHNOLOGIES INC. Stock Palantir Technologies Inc.
+22.60% 46.88B
THE TRADE DESK, INC. Stock The Trade Desk, Inc.
+32.14% 46.51B
ATLASSIAN CORPORATION Stock Atlassian Corporation
-30.71% 42.9B
SEA LIMITED Stock Sea Limited
+71.93% 39.99B
TAKE-TWO INTERACTIVE SOFTWARE, INC. Stock Take-Two Interactive Software, Inc.
-2.58% 26.87B
Other Software
  1. Stock Market
  2. Equities
  3. CLBT Stock
  4. Financials Cellebrite DI Ltd.